Sensus Healthcare
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 35
- Market Cap
- -
- Introduction
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Clinical Trials
3
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars
- Conditions
- Keloid Scar
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- Sensus Healthcare
- Target Recruit Count
- 100
- Registration Number
- NCT04184011
- Locations
- 🇺🇸
Dermatology and Dermatological Surgery, Boynton Beach, Florida, United States
A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
Completed
- Conditions
- Non-melanoma Skin Cancer
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Sensus Healthcare
- Target Recruit Count
- 776
- Registration Number
- NCT03693937
- Locations
- 🇺🇸
Dermatology and Dermatological Surgery, Boynton Beach, Florida, United States
A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Keloid Scars.
- Conditions
- Keloid Scar
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2018-10-03
- Lead Sponsor
- Sensus Healthcare
- Target Recruit Count
- 100
- Registration Number
- NCT03693924
News
No news found